Infex Therapeutics and LifeArc in Collaboration to Defeat Superbugs
Infex Therapeutics has combined forces with medical research charity, LifeArc,…
Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award
The AMR Centre has combined forces to attract much needed investment to…
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development…
A Deal to Fix the Broken Antibiotic Market?
The market for new antibiotics is effectively failing. No novel class of drugs…
BioTrinity, 28-29th April 2020
London Link: biotrinity.com We’re attending BioTrinity 2020 in London,…
More People in the United States Dying from Antibiotic-Resistant Infections than Previously Estimated
Significant progress since 2013 could be lost without more action The…
AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes
Alderley Park, UK The AMR Centre has nominated a preclinical candidate in…
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese…
AMR Centre to join first life sciences delegation to Biomed in Israel
The North’s life sciences landscape will be showcased on an international…